Genky DrugStores Co.,Ltd. [9267.T]
TOKYO, Apr 28 (Pulse News Wire) – Genky Drugstores CO.,LTD. (9267.T) reported its fiscal third-quarter results for the June 2026 quarter, showing revenue missed expectations by approximately ¥4 billion despite maintaining price competitiveness through its EDLP strategy.
Sales growth was hampered by last year's high rice prices, which led to a significant decline in existing store sales during the quarter. However, customer traffic increased by 1.5%, driven by higher footfall in March due to early and heavy pollen dispersal. The company’s operating profit met its plan, reaching ¥11.05 billion, while net income came in at ¥7.85 billion, slightly below forecasts.
Despite falling short of revenue targets, cost management efforts, particularly in personnel expenses and utility costs, helped control general and administrative expenses, leading to improved margins. Looking ahead, Genky DrugStores expects its full-year revenue to grow by 4.31% compared to the previous year, with plans for 61 new stores and eight conversions from large-format stores to regular stores. The company also noted that its capital expenditure would increase to ¥19 billion for the fiscal year ending June 2026.
🟢 Confidence: High AI-translated content.